Home > Income Statement > GUJARAT THEMIS BIOSYN

GUJARAT THEMIS BIOSYN
Revenue

    Back to Income Statement
GUJARAT THEMIS BIOSYN is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GUJARAT THEMIS BIOSYN
Please provide your vote to see the results

GUJARAT THEMIS BIOSYN Last 5 Year Revenue History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹151 Cr₹170 Cr₹148 Cr₹115 Cr₹91 Cr

What is the latest Revenue of GUJARAT THEMIS BIOSYN ?

The latest Revenue ratio of GUJARAT THEMIS BIOSYN is ₹151 Cr based on Mar2025 Standalone results.
Year Revenue
Mar2025₹151 Cr
Mar2024₹170 Cr
Mar2023₹148 Cr
Mar2022₹115 Cr
Mar2021₹91 Cr

How is Revenue of GUJARAT THEMIS BIOSYN Trending?

Years Revenue % Change
Mar2025 ₹151 Cr
-11.20
Mar2024 ₹170 Cr
14.45
Mar2023 ₹148 Cr
29.19
Mar2022 ₹115 Cr
26.82
Mar2021 ₹91 Cr -

Compare Revenue of peers of GUJARAT THEMIS BIOSYN

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GUJARAT THEMIS BIOSYN ₹4,379.1 Cr -7.3% 7.7% 29% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹429,349.0 Cr -3% -1.9% 7.5% Stock Analytics
DIVIS LABORATORIES ₹174,543.0 Cr -3.3% -0.7% -1.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,884.0 Cr -3.8% 2.8% 36.4% Stock Analytics
CIPLA ₹111,077.0 Cr -3% 3% -6.1% Stock Analytics
DR REDDYS LABORATORIES ₹105,388.0 Cr -4.3% -2% 2.5% Stock Analytics


GUJARAT THEMIS BIOSYN Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GUJARAT THEMIS BIOSYN

-7.3%

7.7%

29%

SENSEX

-2.2%

-3.3%

-8.8%


You may also like the below Video Courses